Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients

European Journal of Heart Failure

Volumn 15, Issue 10, 2013, Pages 1138-1147

  Ellis, Katrina L ^a   Cameron, Vicky A ^a   Troughton, Richard W ^a   Frampton, Chris M ^a   Ellmers, Leigh J ^a   Richards, A Mark ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Biomarkers; Diagnosis; Heart failure; MicroRNA; Plasma

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 142 3P; MICRORNA 150; MICRORNA 185; MICRORNA 1909; MICRORNA 199A 3P; MICRORNA 2110; MICRORNA 23A; MICRORNA 27B; MICRORNA 29A; MICRORNA 30B; MICRORNA 324 5P; MICRORNA 342 3P; MICRORNA 423 5P; MICRORNA 598; MICRORNA 940; TROPONIN T; UNCLASSIFIED DRUG;

AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSPNEA; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

BIOMARKERS; DIAGNOSIS; HEART FAILURE; MICRORNA; PLASMA;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; ROC CURVE; STROKE VOLUME; TROPONIN T;

EID: 84884862516     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hft078     Document Type: Article

References (37)

1. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1402. (Pubitemid 35239711)
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
3. D'AlessandraY, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G, Capogrossi MC. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010;31: 2765-2773.
4. CorstenMF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L,Wagner DR, Staessen JA, Heymans S, Schroen B. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010;3:499-506.
5. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM. Mir423-5p as a circulating biomarker for heart failure. Circ Res 2010; 106:1035-1039.
6. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H, Iwai N. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 2010;56:1183-1185.
7. Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N. Assessment of plasma miRNAs in congestive heart failure. Circ J 2011;75:336-340.
8. GorenY, Kushnir M, Zafrir B, Tabak S, Lewis BS, Amir O. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 2012;14:147-154.
9. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC,ThumT. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011;51:872-875.
10. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-2467.
11. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259. (Pubitemid 44079340)
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
13. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287-296. (Pubitemid 27395959)
14. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D,Westermann F, Speleman F, Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009;10:R64.
15. Vandesompele J,DePreter K, Pattyn F, PoppeB, VanRoy N,DePaepeA, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
16. Creemers EE, Tijsen AJ, Pinto YM. Circulating micrornas: Novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012;110:483-495.
17. Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, EschenbacherWH, Dorn LE,Watson MA, Margulies KB, DornGW2nd. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009;119:1263-1271.
18. Xiao J, Liang D, Zhang Y, Liu Y, Zhang H, Liu Y, Li L, Liang X, Sun Y, Chen YH. Micro- RNA expression signature in atrial fibrillation with mitral stenosis. Physiol Genomics 2011;43:655-664.
19. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT. Altered microRNA expression in human heart disease. Physiol Genomics 2007;31: 367-373. (Pubitemid 350127777)
20. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007;116:258-267. (Pubitemid 47196561)
21. Voellenkle C, van Rooij J, Cappuzzello C, Greco S, Arcelli D, Di Vito L, Melillo G, Rigolini R, Costa E, Crea F, Capogrossi MC, Napolitano M, Martelli F. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics 2010;42:420-426.
22. Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, Reinhardt F, Liao R, KriegerM, Jaenisch R, LodishHF, Blelloch R. Loss of cardiacmicroRNA- mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 2009;105:585-594.
23. Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, Abdellatif M. Downregulation of miR-199a derepresses hypoxia-inducible factor-1 alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009;104:879-886.
24. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M. A microRNA signature of hypoxia. Mol Cell Biol 2007;27:1859-1867.
25. Wilfred BR,Wang WX, Nelson PT. Energizing miRNA research: a reviewof the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007;91:209-217. (Pubitemid 46819124)
26. LinZ,Murtaza I,Wang K, Jiao J,Gao J, Li PF. Mir-23a functions downstreamofNFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA 2009;106:12103-12108.
27. Ferretti E, De Smaele E, Miele E, Laneve P, Po A, Pelloni M, Paganelli A, Di Marcotullio L, Caffarelli E, Screpanti I, Bozzoni I, Gulino A. Concerted microrna control of hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J 2008;27:2616-2627.
28. Bijlsma MF, Peppelenbosch MP, Spek CA. Hedgehog morphogen in cardiovascular disease. Circulation 2006;114:1985-1991. (Pubitemid 44665394)
29. Wu L, Cai C,Wang X, Liu M, Li X, Tang H. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett 2011;585:1322-1330.
30. Sawada N, Li Y, Liao JK. Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. Curr Opin Pharmacol 2010;10:116-121.
31. Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD,Washington MK, Paraskeva C, Willson JK, Kaz AM, Kroh EM, Allen A, Fritz BR, Markowitz SD, Tewari M. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008;27:3880-3888. (Pubitemid 351862055)
32. Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptides in the cardiovascular system. Cardiovasc Res 2001;51:489-494. (Pubitemid 32718597)
33. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, SmythDW. Plasma Nterminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-1929.
34. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, Drennan C, Richards M, Turner J, YandleT. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994;343:440-444. (Pubitemid 24059585)
35. Pascual-Figal DA, Casas T, Ordonez-Llanos J, Manzano-Fernandez S, Bonaque JC, Boronat M, Munoz-Esparza C, Valdes M, Januzzi JL. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J 2012;163: 1002-1010.
36. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010;56:1071-1078.
37. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-781 (Pubitemid 37093918)